Cloud Twist Bioscience Launches Synthetic RNA Positive Controls for SARS-CoV-2 Encapsulated in Imagene’s… AIT News Desk Mar 22, 2022 -- Enhances Stability and Enables Robust Global Shipping and Storage at Room Temperature -- Twist Bioscience Corporation, a company enabling…
Life Sciences Henley Ion Announces Promising Technology Developed To Protect Against COVID-19 And Emerging… AIT News Desk Jan 13, 2022 Encouraging results in initial evaluations against airborne SARS-CoV-2 Henley Ion, a New Orleans-based life sciences technology company developing…
Healthcare Management Variational AI Partners With The University Of British Columbia And adMare BioInnovations To Develop… AIT News Desk Dec 17, 2021 Variational AI, developer of state-of-the-art generative AI technology to redefine the economics of drug development by accelerating the discovery of…
Healthcare Management Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in Countries Accepting the CE Mark to… AIT News Desk Dec 6, 2021 Roche announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the…
Mobility DENSO Releases Financials for First Half of Fiscal Year, Shares Long-Term Policy 2030 Progress AIT News Desk Nov 1, 2021 Mobility Supplier Continues to Make Strides Toward Creating a Safer, More Sustainable World for All DENSO, a leading mobility supplier,…
Life Sciences FDA Lists Beckman Coulter Life Sciences RNA Extraction Kit For Use In EUA-Authorized COVID-19 Test AIT News Desk May 29, 2020 Beckman Coulter Life Sciences announced RNAdvance Viral XP has been added to the list of acceptable extraction methods for use in the Centers for…
Life Sciences Ligandal Is Developing Potential Antidote And Vaccine To SARS-CoV-2 AIT News Desk Apr 14, 2020 Innovative approach attempts to treat the root of the cause, not the symptoms and cautions COVID is transmitted through a mist Biological…
Life Sciences ImmunoPrecise Announces Artificial Intelligence Collaboration with EVQLV to Accelerate Vaccine and… AIT News Desk Mar 2, 2020 The partnership with the New York-based artificial intelligence company will focus on high-throughput computational antibody design to derive novel…